Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.

The Prostate

Volumn 70, Issue 16, 2010, Pages 1788-1798

  Zhao, Zhigang ^a   Zeng, Guohua ^b   Zhong, Wen ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EARLY PROSTATE CANCER ANTIGEN, HUMAN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; URETHRA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BODY MASS INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; URETHRA;

EID: 78449265596     PISSN: None     EISSN: 10970045     Source Type: Journal    
DOI: None     Document Type: Article

References (0)